Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | DRD4 | P21917 | 1/20 | 0.38 |
| ▸ | MPO | P05164 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.37 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29432878 | 1.00 | TAAR1 (0.50) | TAAR1MAOAMAOBKMT2APKM | |
| SCHEMBL7802949 | 0.80 | KMT2A (0.44) | TAAR1MAOAMAOBKMT2APKM | |
| SCHEMBL7802952 | 0.80 | KMT2A (0.44) | TAAR1MAOAMAOBKMT2APKM | |
| SCHEMBL11346334 | 0.78 | TAAR1 (0.50) | TAAR1MAOBKMT2AMEN1CYP2A13 | |
| SCHEMBL14290122 | 0.77 | TAAR1 (0.48) | TAAR1KMT2AMEN1IDO1ALDH1A1 | |
| SCHEMBL7769162 | 0.77 | MEN1 (0.40) | KMT2AMEN1ALDH1A1 | |
| SCHEMBL11455975 | 0.77 | TAAR1 (0.48) | TAAR1KMT2AAOC3MEN1CYP2A13 | |
| SCHEMBL31506376 | 0.77 | MEN1 (0.40) | KMT2AMEN1ALDH1A1DRD4 | |
| SCHEMBL11465666 | 0.77 | TAAR1 (0.48) | TAAR1KMT2AMEN1CYP2A13IDO1 | |
| SCHEMBL4049556 | 0.76 | MAOA (0.62) | TAAR1MAOAMAOBAOC3IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3710159-A1 | CATALYST COMPONENTS FOR PROPYLENE POLYMERIZATION | W. R. Grace & Co. - Conn. (US) | 2020-09-23 | — | — | EP | claimed |
| US-8344079-B2 | Molar ratio modifications to larger polyolefin catalysts | BASF CORPORATION (US) | 2013-01-01 | — | — | US | claimed |
| JP-2011508053-A | — | — | 2011-03-10 | — | — | JP | claimed |
| CN-101965369-A | Molar ratio change for larger polyolefin catalysts | BASF CATALYSTS LLC | 2011-02-02 | — | — | CN | claimed |
| EP-2242776-A1 | MOLAR RATIO MODIFICATIONS TO LARGER POLYOLEFIN CATALYSTS | BASF Corporation (US) | 2010-10-27 | — | — | EP | claimed |
| WO-2009088596-A1 | MOLAR RATIO MODIFICATIONS TO LARGER POLYOLEFIN CATALYSTS | BASF CATALYSTS LLC (US) | 2009-07-16 | — | — | WO | claimed |
| US-20090171044-A1 | MOLAR RATIO MODIFICATIONS TO LARGER POLYOLEFIN CATALYSTS | BASF CATALYSTS LLC (US) | 2009-07-02 | — | — | US | claimed |
| US-20260103548-A1 | PROCESS FOR PRODUCING POLYPROPYLENE-ETHYLENE RANDOM COPOLYMER RESIN WITH SUSTAINABLE REACTOR OPERABILITY | W. R. GRACE & CO.-CONN. | 2026-04-16 | — | — | US | disclosed |
| EP-3592783-B1 | ELECTRON DONORS FOR ZIEGLER-NATTA PRECATALYST PREPARATION AND CATALYST SYSTEM FOR OLEFIN POLYMERIZATION | GRACE W R & CO (US) | 2025-11-12 | — | — | EP | disclosed |
| US-20250235842-A1 | GAS-PHASE PROCESS FOR MAKING POLYPROPYLENE RANDOM COPOLYMERS | W.R. GRACE & CO.-CONN (US) | 2025-07-24 | — | — | US | disclosed |
| US-20250145745-A1 | HIGH MFR POLYPROPYLENE FOR MELTBLOWN NONWOVEN APPLICATIONS | W. R. GRACE & CO.-CONN. | 2025-05-08 | — | — | US | disclosed |
| US-20250109220-A1 | Olefin Polymerization Catalyst Comprising Magnesium, Titanium, an Epoxy Compound and an Internal Electron Donor, Such as a 1,2-Phenylene Dibenzoate-Based Compound | W. R. GRACE & CO.-CONN. | 2025-04-03 | — | — | US | disclosed |
| US-12240925-B2 | Process for preparing solid catalyst components for olefin polymerization | W. R. GRACE & CO.- CONN. (US) | 2025-03-04 | — | — | US | disclosed |
| EP-0950649-B1 | A process for preparing oxyalkylene derivatives in the presence of phosphine oxides | MITSUI CHEMICALS INC (JP) | 2003-03-26 | — | — | EP | disclosed |
| US-6153794-A | Phosphine sulfide, a manufacturing process therefor and use thereof | MITSUI CHEMICALS, INC. (JP) | 2000-11-28 | — | — | US | disclosed |
| US-6130346-A | ESTERIFICATION, CARBONATION, SULFONATION, ETHERIFICATION | MITSUI CHEMICALS, INC. (JP) | 2000-10-10 | — | — | US | disclosed |
| EP-0972776-A1 | A phosphine sulfide, a manufacturing process therefor and a use thereof | Mitsui Chemicals, Inc. (JP) | 2000-01-19 | — | — | EP | disclosed |
| CN-1235141-A | Process for preparing organic compound | MITSUI CHEMICALS INC (JP) | 1999-11-17 | — | — | CN | disclosed |
| EP-0950649-A1 | A process for preparing oxyalkylene derivatives in the presence of phosphine oxides | Mitsui Chemicals, Inc. (JP) | 1999-10-20 | — | — | EP | disclosed |
| US-4236012-A | ANALGESICS, ANTIINFLAMMATORY AGENTS, MUSCLE RELAXANTS | Nippon Chemiphar Company, Limited (JP) | 1980-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12240925-B2 | Process for preparing solid catalyst components for olefin polymerization | POF1B, PPOX, OGFOD1 | TAAR1 3916/4885MAOA 2958/4885MAOB 2817/4885 |
| US-20260103548-A1 | PROCESS FOR PRODUCING POLYPROPYLENE-ETHYLENE RANDOM COPOLYMER RESIN WITH SUSTAINABLE REACTOR OPERABILITY | CCT4, PTGER1, TCP1 | TAAR1 1463/4885MAOA 3117/4885MAOB 3617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.